Ripasudil Dihydrochloride is a potent Rho-kinase inhibitor used in the treatment of ocular hypertension and open-angle glaucoma, where it acts by relaxing ocular blood vessels to facilitate aqueous humor… Read more
Ripasudil Dihydrochloride is a potent Rho-kinase inhibitor used in the treatment of ocular hypertension and open-angle glaucoma, where it acts by relaxing ocular blood vessels to facilitate aqueous humor outflow. As a pharmaceutical reference standard, this compound is essential for supporting rigorous quality control and analytical testing protocols in laboratory environments. Researchers utilize this category to access high-quality related compounds, including synthetic impurities, degradation products, and stable isotope-labelled standards, which are critical for accurate impurity profiling and method validation. These reference materials enable laboratories to ensure regulatory compliance and maintain precision during bioanalytical studies or stability testing. By providing reliable standards for identification and quantification, these compounds support the development and maintenance of robust manufacturing processes, ensuring that analytical methods effectively detect and monitor specific molecular characteristics throughout the drug lifecycle.